Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Long-Term Effects Shown from Hemophilia Gene Therapy

Drop of blood

Participants in a clinical trial testing a one-time genetic therapy to treat a rare form of hemophilia sharply reduced their bleeding incidents after a year, with few adverse effects, none considered serious. . . . → Read More: Long-Term Effects Shown from Hemophilia Gene Therapy

Univ. Licenses Barrett’s Esophagus Detection Device

Cancer magnified

A medical device company is licensing a minimally-invasive technology developed in university labs for detection of Barrett’s esophagus, a condition that often leads to esophageal cancer. . . . → Read More: Univ. Licenses Barrett’s Esophagus Detection Device

Genetic Repair Company Starts-Up, Gains $87 Million

David Liu

A company is getting underway to develop therapies that extend genome editing to repair genetic disruptions, not just remove them from DNA. . . . → Read More: Genetic Repair Company Starts-Up, Gains $87 Million

Genentech Gains Microbe Drug Discovery Tech in $1B Deal

Collecting soil samples

Biotechnology company Genentech is licensing a process from a start-up enterprise that discovers small molecule drugs from naturally occurring microbes found in soil. . . . → Read More: Genentech Gains Microbe Drug Discovery Tech in $1B Deal

Univ. Spinoff Qualifies for NIH Clinical Program

Kate Rittenhouse-Olson and John Fisk

An enterprise developing a synthetic antibody to treat breast cancer, spun-off from a University at Buffalo research lab, is taking part in a federal program to advance the treatments to clinical trials. . . . → Read More: Univ. Spinoff Qualifies for NIH Clinical Program

3-D Models Devised to Simulate Patients’ Tumors

Gioeli lab group

A university lab is teaming up with a local biotechnology company to develop realistic models of tumors from individual cancer patients, enabling more personalized treatment options. . . . → Read More: 3-D Models Devised to Simulate Patients’ Tumors

Stem Cell Eye Implants Safe, Stop Visual Function Loss

Early results from a clinical trial show implants of replacement retina cells grown from stem cells are safe for people with a form of age-related macular degeneration, and at least stop the loss of visual function. . . . → Read More: Stem Cell Eye Implants Safe, Stop Visual Function Loss

Lilly, Cell Implants Start-Up Partner on Diabetes

Eli Lilly and Company is licensing a technology for implanting pancreatic beta cells in people with type 1 diabetes, from Sigilon Therapeutics Inc., an enterprise making implants of live cells to treat chronic diseases. . . . → Read More: Lilly, Cell Implants Start-Up Partner on Diabetes

New Company Acquires Off-the-Shelf T-Cell Cancer Therapies

A new enterprise is formed to develop treatments for cancer using donated T-cells from the immune system, rather than the patient’s own T-cells, engineered to attack cancer cells. . . . → Read More: New Company Acquires Off-the-Shelf T-Cell Cancer Therapies

Cough Suppressant Produced from Engineered Yeast Cells

A bioengineering group created a process for producing a cough suppressant in the lab, usually derived from opium poppies, but instead from genetically modified brewer’s yeast. . . . → Read More: Cough Suppressant Produced from Engineered Yeast Cells